Unexplained Implantation Failure: Which Tests Help?
A large share of RIF stays “unexplained” after a full, guideline-based work-up — and that is a finding, not a failure of your doctor. The real risk is over-testing: immune panels, “natural killer” cell assays, and exotic treatments are widely marketed but are not endorsed by ASRM or ESHRE for routine RIF. This article separates what the evidence supports from what it doesn’t, so you can say yes to useful tests and no to speculative ones. General education, not individual medical advice.
What the evidence supports
- Cavity evaluation (SHG/hysteroscopy) and treatment of found lesions.
- PGT-A in selected cases (recurrent aneuploidy, advanced age).
- Thrombophilia testing only with a personal/family history or antiphospholipid syndrome.
- Treating uterine abnormalities and lifestyle factors (BMI, smoking).
What is NOT routinely recommended
| Test / treatment | Why it’s contested |
|---|---|
| Routine immune assays (NK cells, alloimmunity) | No validated diagnostic threshold; not guideline-recommended |
| Immunotherapy (IVIG, intralipid, steroids) without indication | No consistent benefit; potential harms |
| Endometrial scratch | Major RCTs (e.g., SSF trial) show no benefit, possible harm |
| Assisted hatching | No consistent improvement in RIF |
| “Receptivity” add-ons without a clear plan | Useful only in defined protocols; easy to over-order |
The over-testing trap
Clinics differ. A test being available is not the same as indicated. Ask for the evidence and the expected change in management for any test offered.
What “unexplained” can and cannot mean
- Can mean: you’ve completed a reasonable work-up and the next step is a careful, evidence-based retry or a documented discussion of donor/gestational-carrier options.
- Cannot mean: that a hidden, expensive panel will inevitably reveal the cause, or that unproven treatment is warranted.
Related reading
- Build the right work-up: What to Review Before Your Next Transfer
- The cause framework: What Is Recurrent Implantation Failure?
- Treatment decisions: Should You Change Your Transfer Protocol After RIF?
- Read your records: How to Read Your IVF Transfer and Implantation Record
Your next step
Unsure which offered tests are evidence-based? The IVF Case Clarity Assessment flags speculative vs supported steps for your case.
Medical disclaimer
General education only; not individual medical advice. Treatment decisions belong with your specialist.
References
- Practice Committee of ASRM. Role of immunotherapy in in vitro fertilization: a committee opinion. Fertil Steril. 2018 (updated).
- ESHRE Guideline Group on RPL. ESHRE guideline: recurrent pregnancy loss. Hum Reprod Open. 2024.
- Coughlan C, et al. Recurrent implantation failure: definition and management. Reprod Biomed Online. 2014.
- SSF Trial collaborators. Endometrial scratching and IVF outcomes. Hum Reprod. 2022.